Veeva Systems announced a 16% year-over-year revenue increase to $882.9 million for Q1 fiscal 2027, with subscription revenues up 15% to $730.2 million. The company highlighted rapid progress in AI integration, including new AI products like Ostro and Vault AI, aiming to transform life sciences industry cloud solutions. Veeva also raised its fiscal 2027 guidance, expecting continued growth and profitability driven by AI-enhanced offerings and expanding customer base. This positions Veeva as a leader in combining industry-specific applications with AI to accelerate drug development and commercialization.
Clean Harbors Co-CEO Gerstenberg has sold 2,500 shares of the company. Insider sales like this can indicate personal financial decisions or views on the company’s stock value. Investors often watch such moves for clues about company prospects, though...
A KeyBank survey reveals that 33% of small business owners have reduced their own income to manage rising costs without raising prices for customers. Despite inflation pressures, 88% remain motivated by the original dream that started their business,...
Concentrix Corporation reported a 1.2% year-over-year decline in Q3 FY26 revenue to $2.45 billion, missing analyst estimates. The company took a significant $1 billion goodwill impairment charge, reflecting challenges in profitability with an operati...
CoinShares faced a tough first half of FY26 with revenue and EBITDA declines due to falling digital asset prices and changing product mix. Asset Management revenue dropped 32.9% year-over-year to $40 million as assets under management (AuM) fell to $...
1919 Investment Counsel, a subsidiary of Stifel Financial, has been ranked No. 33 nationally on Barron's 2026 Top 100 Registered Investment Advisor (RIA) Firms list for the seventh consecutive year. This recognition reflects the firm's strong commitm...
